AI assistant
Sending…
RESMED INC — Director's Dealing 2018
Jun 4, 2018
30071_dirs_2018-06-04_85f76763-f349-48b5-9286-725f043c1490.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2018-06-01
Reporting Person: Hollingshead James (President, Sleep Business)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-06-01 | ResMed Common Stock | S | 600 | $102.80 | Disposed | 60863 | Direct |
Footnotes
F1: The transaction was conducted under a Rule10b5-1 Plan.
F2: Includes 202 shares of ResMed stock purchased on April 30, 2018, through the ResMed Employee Stock Purchase Plan.
More from RESMED INC
Regulatory Filings
2026
May 26
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 10
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 3
Interim / Quarterly Report
2026
Jan 30
Earnings Release
2026
Jan 29